Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Chemotherapy remains restricted by poor drug delivery efficacy due to the heterogenous nature of tumor. Herein, we presented a novel nanoparticle that could not only response to the tumor microenvironment but also modulate it for deep tumor penetration and combination therapy. The intelligent nanoparticle (IDDHN) was engineered by hyaluronidase (HAase)-triggered size shrinkable hyaluronic acid shells, which were modified with NIR laser sensitive nitric oxide donor (HN), small-sized dendrimeric prodrug (IDD) of doxorubicin (DOX) as chemotherapy agent and indocyanine green (ICG) as photothermal agent into a single nanoparticle. IDDHN displayed synergistic deep penetration both in vitro and in vivo, owing to the enzymatically degradable HN shell mediated by HAase and laser-enhanced NO release triggered deep penetration upon strong hyperthermia effect of ICG under the NIR laser irradiation. The therapeutic effect of IDDHN was verified in 4T1 xenograft tumor model, and IDDHN showed a much better antitumor efficiency with few side effects upon NIR laser irradiation. Therefore, the valid of this study might provide a novel tactic for engineering nanoparticles both response to and modulate the tumor microenvironment for improving penetration and heterogeneity distribution of therapeutic agents in tumor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
Nitric oxide donors: chemical activities and biological applications
Wang, P. G., Xian, M., Tang, X., Wu, X., Wen, Z., Cai, T., & Janczuk, A. J. (2002) · Chemical Reviews · doi:10.1021/cr000040l · Cited by 1,337
Time Evolution of the Nanoparticle Protein Corona
Casals, E., Pfaller, T., Duschl, A., Oostingh, G. J., & Puntes, V. (2010) · ACS Nano · doi:10.1021/nn901372t · Cited by 1,211 · cited 1×
“3A), which could influence the detection [57,58].”
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D., & Takayama, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.045 · Cited by 1,172 · cited 1×
“MCSs could simulate the in vivo status of tumor, such as poor drug penetration, and viable rim with gradients of oxygen tension [51].”
BackgroundRethinking cancer nanotheranostics
Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.24 · Cited by 1,102
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Wong, C., Stylianopoulos, T., Cui, J., Martin, J., Chauhan, V. P., Jiang, W., Popović, Z., Jain, R. K., Bawendi, M. G., & Fukumura, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018382108 · Cited by 1,062
Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization
Sun, Q., Zhou, Z., Qiu, N., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606628 · Cited by 1,058
Hyaluronidases: Their Genomics, Structures, and Mechanisms of Action
Stern, R., & Jedrzejas, M. J. (2006) · Chemical Reviews · doi:10.1021/cr050247k · Cited by 804
Zheng, M., Yue, C., Ma, Y., Gong, P., Zhao, P., Zheng, C., Sheng, Z., Zhang, P., Wang, Z., & Cai, L. (2013) · ACS Nano · doi:10.1021/nn400334y · Cited by 795
Transport of Molecules, Particles, and Cells in Solid Tumors
Jain, R. K. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.241 · Cited by 691
Investigating the optimal size of anticancer nanomedicine
Tang, L., Yang, X., Yin, Q., Cai, K., Wang, H., Chaudhury, I., Yao, C., Zhou, Q., Kwon, M., Hartman, J. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411499111 · Cited by 654
Self-citationFan, W., Lu, N., Huang, P., Liu, Y., Yang, Z., Wang, S., Yu, G., Liu, Y., Hu, J., He, Q., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201610682 · Cited by 640
Investigating the Impact of Nanoparticle Size on Active and Passive Tumor Targeting Efficiency
Sykes, E. A., Chen, J., Zheng, G., & Chan, W. C. W. (2014) · ACS Nano · doi:10.1021/nn500299p · Cited by 635
Hyaluronic acid for anticancer drug and nucleic acid delivery
Dosio, F., Arpicco, S., Stella, B., & Fattal, E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.011 · Cited by 596
Improving drug delivery to solid tumors: Priming the tumor microenvironment
Khawar, I. A., Kim, J. H., & Kuh, H.-J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.018 · Cited by 533
Altınoǧlu, E. I., Russin, T. J., Kaiser, J. M., Barth, B. M., Eklund, P. C., Kester, M., & Adair, J. H. (2008) · ACS Nano · doi:10.1021/nn800448r · Cited by 430
Control of polymeric nanoparticle size to improve therapeutic delivery
Hickey, J. W., Santos, J. L., Williford, J.-M., & Mao, H.-Q. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.006 · Cited by 379
Ganesh, S., Iyer, A. K., Morrissey, D. V., & Amiji, M. M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.077 · Cited by 362
Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective
Götte, M., & Yip, G. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1464 · Cited by 340
A Nanoparticle Size Series for In Vivo Fluorescence Imaging
Popović, Z., Liu, W., Chauhan, V. P., Lee, J., Wong, C., Greytak, A. B., Insin, N., Nocera, D. G., Fukumura, D., Jain, R. K., et al. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201003142 · Cited by 332
Hyaluronidase To Enhance Nanoparticle-Based Photodynamic Tumor Therapy
Gong, H., Chao, Y., Xiang, J., Han, X., Song, G., Feng, L., Liu, J., Yang, G., Chen, Q., & Liu, Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b00068 · Cited by 322
Jiang, T., Mo, R., Bellotti, A., Zhou, J., & Gu, Z. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201303222 · Cited by 298
Wang, T., Wang, D., Yu, H., Wang, M., Liu, J., Feng, B., Zhou, F., Yin, Q., Zhang, Z., Huang, Y., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b07706 · Cited by 295
Ruan, S., Cao, X., Cun, X., Hu, G., Zhou, Y., Zhang, Y., Lu, L., He, Q., & Gao, H. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.006 · Cited by 290
Self-citationTailoring nanoparticle designs to target cancer based on tumor pathophysiology
Sykes, E. A., Dai, Q., Sarsons, C. D., Chen, J., Rocheleau, J. V., Hwang, D. M., Zheng, G., Cramb, D. T., Rinker, K. D., & Chan, W. C. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521265113 · Cited by 281
Zhang, K., Xu, H., Jia, X., Chen, Y., Ma, M., Sun, L., & Chen, H. (2016) · ACS Nano · doi:10.1021/acsnano.6b04921 · Cited by 265
Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors
Miao, L., Lin, C. M., & Huang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.017 · Cited by 264
Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation
Ruan, S., Hu, C., Tang, X., Cun, X., Xiao, W., Shi, K., He, Q., & Gao, H. (2016) · ACS Nano · doi:10.1021/acsnano.6b05070 · Cited by 263
Self-citationNanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
Yang, S., & Gao, H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.004 · Cited by 256
Self-citationLv, G., Guo, W., Zhang, W., Zhang, T., Li, S., Chen, S., Eltahan, A. S., Wang, D., Wang, Y., Zhang, J., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b05419 · Cited by 256
Mediating Passive Tumor Accumulation through Particle Size, Tumor Type, and Location
Perry, J. L., Reuter, K. G., Luft, J. C., Pecot, C. V., Zamboni, W., & DeSimone, J. M. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b00021 · Cited by 255
Zhang, L., Gao, S., Zhang, F., Yang, K., Ma, Q., & Zhu, L. (2014) · ACS Nano · doi:10.1021/nn506130t · Cited by 236
Photoswitchable nanoparticles for in vivo cancer chemotherapy
Tong, R., Chiang, H. H., & Kohane, D. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315336110 · Cited by 227
Stirland, D. L., Nichols, J. W., Miura, S., & Bae, Y. H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.026 · Cited by 225
Accumulating nanoparticles by EPR: A route of no return
Ngoune, R., Peters, A., von Elverfeldt, D., Winkler, K., & Pütz, G. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.028 · Cited by 218
Nishikawa, T., Akiyoshi, K., & Sunamoto, J. (1996) · Journal of the American Chemical Society · doi:10.1021/ja953843c · Cited by 215
Guo, R., Tian, Y., Wang, Y., & Yang, W. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201606398 · Cited by 196
Chung, M., Liu, H., Lin, K., Chia, W., & Sung, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201504444 · Cited by 185
Perivascular nitric oxide gradients normalize tumor vasculature
Kashiwagi, S., Tsukada, K., Xu, L., Miyazaki, J., Kozin, S. V., Tyrrell, J. A., Sessa, W. C., Gerweck, L. E., Jain, R. K., & Fukumura, D. (2008) · Nature Medicine · doi:10.1038/nm1730 · Cited by 183
Ruan, S., He, Q., & Gao, H. (2015) · Nanoscale · doi:10.1039/c5nr01408e · Cited by 173
Self-citationA Simple Dual-pH Responsive Prodrug-Based Polymeric Micelles for Drug Delivery
Mao, J., Li, Y., Wu, T., Yuan, C., Zeng, B., Xu, Y., & Dai, L. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b04247 · Cited by 162
Yang, Y. L., Zhang, X., & Qiu, L. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.096 · Cited by 142
Self-citationStylianopoulos, T., Soteriou, K., Fukumura, D., & Jain, R. K. (2013) · Annals of Biomedical Engineering · doi:10.1007/s10439-012-0630-4 · Cited by 139
Increased hyaluronidase levels in breast tumor metastases
Bertrand, P., Girard, N., Duval, C., d'Anjou, J., Chauzy, C., Ménard, J.-F., & Delpech, B. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971104)73:3<327::aid-ijc4>3.0.co;2-1 · Cited by 135
Nguyen, S. C., Zhang, Q., Manthiram, K., Ye, X., Lomont, J. P., Harris, C. B., Weller, H., & Alivisatos, A. P. (2016) · ACS Nano · doi:10.1021/acsnano.5b06623 · Cited by 132
Su, S., Tian, Y., Li, Y., Ding, Y., Ji, T., Wu, M.-Y., Wu, Y. F., & Nie, G. (2015) · ACS Nano · doi:10.1021/nn505729m · Cited by 132
Light-Induced Acid Generation on a Gatekeeper for Smart Nitric Oxide Delivery
Choi, H. W., Kim, J., Kim, J., Kim, Y., Song, H. B., Kim, J. H., Kim, K., & Kim, W. J. (2016) · ACS Nano · doi:10.1021/acsnano.5b07483 · Cited by 127
Xiao, W., Xiong, J., Zhang, S., Xiong, Y., Zhang, H., & Gao, H. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.01.011 · Cited by 118
Self-citationCun, X., Ruan, S., Chen, J., Zhang, L., Li, J., He, Q., & Gao, H. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.12.002 · Cited by 117
Self-citationZhao, Q., Zhang, J., Song, L., Ji, Q., Yao, Y., Cui, Y., Shen, J., Wang, P. G., & Kong, D. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.045 · Cited by 114
Mi, P., Kokuryo, D., Cabral, H., Kumagai, M., Nomoto, T., Aoki, I., Terada, Y., Kishimura, A., Nishiyama, N., & Kataoka, K. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.038 · Cited by 113
Kibria, G., Hatakeyama, H., Ohga, N., Hida, K., & Harashima, H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.094 · Cited by 107
Tumor-Homing, Size-Tunable Clustered Nanoparticles for Anticancer Therapeutics
Kim, J., Lee, Y. M., Kang, Y., & Kim, W. J. (2014) · ACS Nano · doi:10.1021/nn503349g · Cited by 106
Ruan, S., Xiao, W., Hu, C., Zhang, H., Rao, J., Wang, S., Wang, X., He, Q., & Gao, H. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b02303 · Cited by 103
Self-citationHuang, W., Lin, J.-N., Hsieh, J., Chou, S., Lai, C., Yun, E.-J., Lo, U., Pong, R.-C., Lin, Y.-H., & Lin, Y.-H. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b10029 · Cited by 97
Song, Q., Tan, S., Zhuang, X., Guo, Y., Zhao, Y., Wu, T., Qi, Y., Si, L., & Zhang, Z. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5003009 · Cited by 90
Xiao, W., Ruan, S., Yu, W., Wang, R., Hu, C., Liu, R., & Gao, H. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00475 · Cited by 84
Self-citationHu, G., Zhang, H., Zhang, L., Ruan, S., He, Q., & Gao, H. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.11.025 · Cited by 74
Self-citationPang, H., Braun, G. B., She, Z., Kotamraju, V. R., Sugahara, K. N., Teesalu, T., & Ruoslahti, E. I. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.006 · Cited by 69
Ding, J., Liang, T., Zhou, Y., He, Z., Min, Q., Jiang, L., & Zhu, J. (2016) · Nano Research · doi:10.1007/s12274-016-1328-y · Cited by 64
Tao, X., Jin, S., Wu, D., Ling, K., Yuan, L., Lin, P., Xie, Y., & Yang, X. (2015) · Nanomaterials · doi:10.3390/nano6010002 · Cited by 53
Self-citationKinoshita, R., Ishima, Y., Ikeda-Imafuku, M., Kragh‐Hansen, U., Fang, J. Q., Nakamura, H., Chuang, V. T. G., Tanaka, R., Maeda, H., Kodama, A., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.036 · Cited by 52
Hu, G., Wang, Y., He, Q., & Gao, H. (2015) · RSC Advances · doi:10.1039/c5ra18833d · Cited by 42
Self-citationChung, M., Liu, H., Lin, K., Chia, W., & Sung, H. (2015) · Angewandte Chemie · doi:10.1002/ange.201504444 · Cited by 23
Liu, Y., Lu, Z., Mei, L., Yu, Q., Tai, X., Wang, Y., Shi, K., Zhang, Z., & He, Q. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b12611 · Cited by 22
Cited by
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
Recent progress in drug delivery
Li, C., Wang, J., Wang, Y., Gao, H., Wei, G., Huang, Y., Yu, H., Gan, Y., Wang, Y., Mei, L., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.003 · Cited by 818
Self-citationAdvances of nanoparticles as drug delivery systems for disease diagnosis and treatment
Liu, R., Luo, C., Pang, Z., Zhang, J., Ruan, S., Wu, M., Wang, L., Sun, T., Li, N., Han, L., et al. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.05.032 · Cited by 516
Self-citationSize-Tunable Strategies for a Tumor Targeted Drug Delivery System
Yu, W., Liu, R., Zhou, Y., & Gao, H. (2020) · ACS Central Science · doi:10.1021/acscentsci.9b01139 · Cited by 489
Self-citationTian, H., Zhang, T., Qin, S., Huang, Z., Zhou, L., Shi, J., Nice, E. C., Xie, N., Huang, C., & Shen, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01320-5 · Cited by 426
Metadata
- Authors
- Hu, C., Cun, X., Ruan, S., Liu, R., Xiao, W., Yang, X., Yang, Y., Yang, C., & Gao, H.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 168
- Pages
- 64-75
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2795161016
- Cited by
- 276
- References
- 67
- FWCI
- 15.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.